On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
functional unblinding
.
Show all posts
Showing posts with label
functional unblinding
.
Show all posts
Monday, February 16, 2026
The Statistical Magic Trick: How Trials Share Results While Staying Blind
›
In the world of clinical research, "breaking the blind" is typically a cardinal sin. Yet, high-stakes Phase 3 trials like ORIGIN...
Thursday, June 26, 2025
Low-Dose Active-Control Trials in Psychedelic and CNS Drug Development
›
This week, Compass Pathways plc (Nasdaq: CMPS) announced the successful achievement of the primary endpoint in the ongoing Phase 3 COMP005 t...
Wednesday, June 19, 2024
Functional Unblinding in Double-blind, Randomized, Controlled Trials (RCTs)
›
Earlier this month, FDA advisory committee declined to endorse Lykos Therapeutics’ application to market its psychedelic drug MDNA, also k...
›
Home
View web version
